Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,335.86
(
-0.26%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: go seek post# 12057

Tuesday, 06/24/2008 12:08:48 AM

Tuesday, June 24, 2008 12:08:48 AM

Post# of 19309
Re: Priority review

Dr. Cox was mistaken and retracted the comments you cited on the 1Q08 CC in May (#msg-29148987, about 2/3 of the way down):

>>
The near-term events include, first of all, concluding an ATryn U.S. commercialization and development partner, and very importantly completing the filing of the U.S. heredity deficiency BLA early in the third quarter. Next, obtaining a determination of priority review status from the FDA, and supporting the FDA review timeline to reach a conclusion in early 2009.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today